PTGS2 and neoplasm: Elevated IFN sensitivity and inflammatory pathways were identified in EphA2KO tumours as the basis for the enhanced immune reaction, while they had decreased activity of TGF/SMAD signalling and the downstream effector Ptgs2/cyclooxygenase-2 (COX-2) [57].